Next Article in Journal
Challenges and Outcomes of a Randomized Study of Early Nutrition Support during Autologous Stem-Cell Transplantation
Previous Article in Journal
Predictors of Recurrence after Radiotherapy for Non-Melanoma Skin Cancer
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Screening for Distress in Patients with Cancer: Methodologic Considerations

1
Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada
2
Elisabeth Bruyere Hosp, Div Palliat Med, Ottawa, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2014, 21(2), 330-333; https://doi.org/10.3747/co.21.1794
Submission received: 2 January 2014 / Revised: 5 February 2014 / Accepted: 4 March 2014 / Published: 1 April 2014

Abstract

Distress has been declared the 6th vital sign in Canadian cancer care. Accordingly, health care professionals in Canada are expected to screen for distress in patients with cancer, for which a toolkit has been developed. Identifying patients who may be in need of further resources has the potential to improve quality of care because those patients are more likely to have their existing distress identified and to be referred for appropriate follow-up services. The present article briefly reviews the background literature and the validation of the measures in the toolkit, and highlights future directions for methodologic validation of the toolkit for use according to the protocol.
Keywords: screening for distress; validation; esas; Distress Thermometer; Canadian problem checklist screening for distress; validation; esas; Distress Thermometer; Canadian problem checklist

Share and Cite

MDPI and ACS Style

Feldstain, A.; Tomei, C.; Bélanger, M.; Lebel, S. Screening for Distress in Patients with Cancer: Methodologic Considerations. Curr. Oncol. 2014, 21, 330-333. https://doi.org/10.3747/co.21.1794

AMA Style

Feldstain A, Tomei C, Bélanger M, Lebel S. Screening for Distress in Patients with Cancer: Methodologic Considerations. Current Oncology. 2014; 21(2):330-333. https://doi.org/10.3747/co.21.1794

Chicago/Turabian Style

Feldstain, A., C. Tomei, M. Bélanger, and S. Lebel. 2014. "Screening for Distress in Patients with Cancer: Methodologic Considerations" Current Oncology 21, no. 2: 330-333. https://doi.org/10.3747/co.21.1794

APA Style

Feldstain, A., Tomei, C., Bélanger, M., & Lebel, S. (2014). Screening for Distress in Patients with Cancer: Methodologic Considerations. Current Oncology, 21(2), 330-333. https://doi.org/10.3747/co.21.1794

Article Metrics

Back to TopTop